Investor Relations

Investor Relations

Aug 5 8:30 AM EDT Aug 5, 2021 | 8:30 AM EDT
Regeneron Pharmaceuticals Q2 2021 Earnings Conference Call

Jun 29 10:00 AM EDT Jun 29, 2021 | 10:00 AM EDT
Guggenheim Biopharma Strategy Series – Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation

Jun 22 8:00 AM EDT Jun 22, 2021 | 8:00 AM EDT
BMO Biopharma Day

btn Events

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.

Analyst Center


Analyst Center

Interactive and downloadable financial data for investors and analysts

btn Analyst Center

Contact us

Investor Relations


Media Relations

Email Alerts

IR Tools